Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
alpha1h (1 trial)
Urinary Bladder Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (1 total)